Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

CDK 4/6 inhibitors for older women with HR-positive breast cancer

Harpreet Singh - FDA, USA
CDK 4/6 inhibitors for older women with HR-positive breast cancer ( Harpreet Singh - FDA, USA )
9 Dec 2017

Reducing risk of breast cancer recurrence and death with increased dose density

Prof Richard Gray - University of Oxford, Oxford, UK
Reducing risk of breast cancer recurrence and death with increased dose density ( Prof Richard Gray - University of Oxford, Oxford, UK )
9 Dec 2017

Breast cancer therapy resistance mediated by FGFR amplification

Dr Luigi Formisano - Vanderbilt University Medical Center, Nashville, USA
Breast cancer therapy resistance mediated by FGFR amplification ( Dr Luigi Formisano - Vanderbilt University Medical Center, Nashville, USA )
9 Dec 2017

The significance of CEACAM 5 in metastases of triple negative breast cancer

Emily Powell - MD Anderson Cancer Center, Houston, USA
The significance of CEACAM 5 in metastases of triple negative breast cancer ( Emily Powell - MD Anderson Cancer Center, Houston, USA )
9 Dec 2017

Results of the MONALEESA 7 trial

Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA
Results of the MONALEESA 7 trial ( Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA )
9 Dec 2017

The REACT trial: Celecoxib vs placebo for primary breast cancer

Prof Charles Coombes - Imperial College School of Medicine, London, UK
The REACT trial: Celecoxib vs placebo for primary breast cancer ( Prof Charles Coombes - Imperial College School of Medicine, London, UK )
9 Dec 2017

Rationale and recruitment in the PARTNER trial

Dr Jean Abraham - University of Cambridge, Cambridge, UK
Rationale and recruitment in the PARTNER trial ( Dr Jean Abraham - University of Cambridge, Cambridge, UK )
9 Dec 2017

The role of axiliary node dissection in modern breast cancer surgery

Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy
The role of axiliary node dissection in modern breast cancer surgery ( Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy )
9 Dec 2017

Anastrozole duration for post-menopausal breast cancer patients after 5 years of endocrine therapy

Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria
Anastrozole duration for post-menopausal breast cancer patients after 5 years of endocrine therapy ( Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )
9 Dec 2017

ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence

Dr Ivana Sestak - Queen Mary University of London, London, UK
ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence ( Dr Ivana Sestak - Queen Mary University of London, London, UK )
9 Dec 2017

Predicting late breast cancer recurrence with screening assays

Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, UK
Predicting late breast cancer recurrence with screening assays ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, UK )
9 Dec 2017

The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression via exemestane to tamoxifen alone

Prof Gini Fleming - University of Chicago, Chicago, USA
The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression via exemestane to tamoxifen alone ( Prof Gini Fleming - University of Chicago, Chicago, USA )
8 Dec 2017